207 related articles for article (PubMed ID: 15962175)
41. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
Schalekamp MA; Derkx FH; van den Meiracker AH
J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin-(1-7): beyond its central effects on blood pressure.
Gironacci MM
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):209-16. PubMed ID: 26287021
[TBL] [Abstract][Full Text] [Related]
43. Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats.
Ji H; Menini S; Zheng W; Pesce C; Wu X; Sandberg K
Exp Physiol; 2008 May; 93(5):648-57. PubMed ID: 18296494
[TBL] [Abstract][Full Text] [Related]
44. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
Li XY; Peng Y; Bu XW; Yao J; Yao L
Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation.
Ferrario CM
Hypertension; 2006 Mar; 47(3):515-21. PubMed ID: 16365192
[TBL] [Abstract][Full Text] [Related]
46. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
47. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
48. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
[TBL] [Abstract][Full Text] [Related]
49. Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system.
Ocaranza MP; Michea L; Chiong M; Lagos CF; Lavandero S; Jalil JE
Clin Sci (Lond); 2014 Nov; 127(9):549-57. PubMed ID: 25029123
[TBL] [Abstract][Full Text] [Related]
50. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.
Schindler C; Bramlage P; Kirch W; Ferrario CM
Vasc Health Risk Manag; 2007; 3(1):125-37. PubMed ID: 17583183
[TBL] [Abstract][Full Text] [Related]
51. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
52. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
[TBL] [Abstract][Full Text] [Related]
54. Pathways of angiotensin-(1-7) metabolism in the kidney.
Chappell MC; Allred AJ; Ferrario CM
Nephrol Dial Transplant; 2001; 16 Suppl 1():22-6. PubMed ID: 11369816
[TBL] [Abstract][Full Text] [Related]
55. Alamandine: a new member of the angiotensin family.
Villela DC; Passos-Silva DG; Santos RA
Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):130-4. PubMed ID: 24389733
[TBL] [Abstract][Full Text] [Related]
56. New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?
Gromotowicz-Poplawska A; Szoka P; Kolodziejczyk P; Kramkowski K; Wojewodzka-Zelezniakowicz M; Chabielska E
Exp Biol Med (Maywood); 2016 Nov; 241(17):1888-1899. PubMed ID: 27439538
[TBL] [Abstract][Full Text] [Related]
57. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.
Dell'Italia LJ; Meng QC; Balcells E; Wei CC; Palmer R; Hageman GR; Durand J; Hankes GH; Oparil S
J Clin Invest; 1997 Jul; 100(2):253-8. PubMed ID: 9218500
[TBL] [Abstract][Full Text] [Related]
58. New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.
Etelvino GM; Peluso AA; Santos RA
Curr Hypertens Rep; 2014 Jun; 16(6):433. PubMed ID: 24760442
[TBL] [Abstract][Full Text] [Related]
59. Differential actions of angiotensin-(1-7) in the kidney.
Chappell MC; Diz DI; Yunis C; Ferrario CM
Kidney Int Suppl; 1998 Dec; 68():S3-6. PubMed ID: 9839274
[TBL] [Abstract][Full Text] [Related]
60. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders.
Rocha NP; Simoes E Silva AC; Prestes TRR; Feracin V; Machado CA; Ferreira RN; Teixeira AL; de Miranda AS
Curr Med Chem; 2018; 25(28):3333-3352. PubMed ID: 29484978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
